Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • This is How CRI Funded Scientists are Fighting Breast Cancer

    A Global Challenge  Breast cancer poses a formidable challenge to healthcare, being one of the most common…
    October 20, 2023| Ajit Muley, PhD
  • Honoring Hispanic Immunologists During National Hispanic Heritage Month

    Immunotherapy is the most forward-thinking and promising treatment for many types of cancers. Outcomes for childhood cancers,…
    October 12, 2023| Max Mallet
  • Prostate Cancer: A Unique and Common Cancer Affecting Men 

    Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects…
    October 2, 2023| Max Mallet
  • 2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine 

    On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel…
    October 2, 2023| Max Mallet
  • How CRI-Funded Scientists are Reducing and Guarding Against Childhood Cancers 

    A cancer diagnosis is always extremely difficult news for a patient and their family. It can be…
    September 15, 2023| Max Mallet
  • Cancer Cabinet Declares Updates to President Biden’s Cancer Moonshot Initiative 

    U.S. President Joe Biden’s administration is following through on last year’s commitment to reignite the White House…
    September 13, 2023| Max Mallet
  • Dr. Jill O’Donnell-Tormey on the State of Cancer Immunotherapy and the Contributions CRI Continues to Make to the Field 

    iFrame is not supported! Recently, the Cancer Research Institute’s (CRI) CEO and Director of Scientific Affairs Jill…
    September 12, 2023| CRI Staff
  • Join #TeamCRI and Plan Your Own Tailgate for a Purpose

    The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,…
    August 30, 2023| CRI Staff
  • CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines

    Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first…
    August 28, 2023| CRI Staff
Previous Page
1 … 9 10 11 12 13 … 20
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute